Novartis/Chiron Deal To Close April 20
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis' acquisition of Chiron is set to close on April 20, the firms said April 19
You may also be interested in...
Novartis’ Diovan Growth Bolstered By Awareness Program, Part D
The company reported double-digit sales growth for its top three products in the second quarter.
Vasella Knocks AstraZeneca Acquisition Rumor
Novartis CEO Daniel Vasella dismissed rumors that the firm is considering acquisition of rival drug maker AstraZeneca July 17
Novartis’ Diovan Growth Bolstered By Awareness Program, Part D
The company reported double-digit sales growth for its top three products in the second quarter.